Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery

Table 2 Clinicopathologic features in the AC and ASC groups

Characteristics		AC	ASC	P^a	Overall survival
Characteristics		(n = 240)	(n = 130)		HR (95% CI)	P^b
Age	≤40	66	22	0.029	0.67 (0.23–1.98)	0.471
Age	>40	174	108		0.70 (0.45–1.11)	0.129
Size	<4 cm	162	85	0.729	0.77 (0.44–1.33)	0.345
Size	≥4 cm	78	45		0.65 (0.34–1.24)	0.192
LNM	No	172	95	0.809	0.64 (0.35–1.18)	0.153
LNM	Yes	68	35		0.88 (0.50–1.56)	0.660
LVSI	No	139	61	0.049	0.71 (0.38–1.33)	0.289
LVSI	Yes	101	69		0.71 (0.40–1.24)	0.223
DSI	<1/2	135	60	0.065	0.57 (0.26–1.24)	0.158
DSI	≥1/2	105	70		0.71 (0.43–1.18)	0.187
SCC-Ag	≤5 ng/ml	233	118	0.013	0.72 (0.46–1.11)	0.138
SCC-Ag	>5 ng/ml	7	12		0.34 (0.09–1.28)	0.110

P^a-value, clinicopathological features were compared between patients with AC and those with ASC; HR and P^b-value, OS were compared between patients with AC and those with ASC using log-rank tests

ISSN: 1471-2407